Brian Shuch

14PUBLICATIONS
101CO-AUTHORS
Solid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Dec 22, 2025
Genetically Engineered Human iPS Cell-Derived Kidney Organoid Recapitulates an Early Stage of ALK Fusion Gene-Associated Renal Tumorigenesis.

Go Noguchi, Masaya Baba, Shinji Ohtake

|Sep 20, 2024
Adjuvant Nivolumab for Localized Renal Cell Carcinoma at High Risk of Recurrence After Nephrectomy: Part B of the Randomized, Placebo-Controlled, Phase III CheckMate 914 Trial.

Robert J Motzer, Axel Bex, Paul Russo

|Sep 10, 2024
Final Overall Survival Analysis of S1500: A Randomized, Phase II Study Comparing Sunitinib With Cabozantinib, Crizotinib, and Savolitinib in Advanced Papillary Renal Cell Carcinoma.

Pedro Barata, Catherine Tangen, Melissa Plets

|Jul 17, 2024
Pathological concordance rate and outcomes by subtype in advanced papillary renal cell carcinoma.

Abhishek Tripathi, Catherine M Tangen, Melissa Plets

|Jul 01, 2024
NAPRT Silencing in FH-Deficient Renal Cell Carcinoma Confers Therapeutic Vulnerabilities via NAD+ Depletion.

Katelyn J Noronha, Karlie N Lucas, Sateja Paradkar

|May 31, 2023
FH Variant Pathogenicity Promotes Purine Salvage Pathway Dependence in Kidney Cancer.

Blake R Wilde, Nishma Chakraborty, Nedas Matulionis

Pageof 3

Frequent Collaborators

2 joint publications

Edward D Esplin

2 joint publications

Blake R Wilde

2 joint publications

Sumanta K Pal

2 joint publications

Heather R Christofk